VOY-101

· Perceive Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VOY-101, covering 2024-04-11 to 2025-10-15. Get the full timeline:

Most recent: Clinical Trial Update: Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration [Phase 1, Phase 2]